Spinal Cord Injuries may have new treatment option

Today on Biotech Strategy Blog, Pieter Droppert writes about recent research that suggests that paclitaxel may help those with spinal cord injuries (SCI).

Although this animal research has yet to be confirmed in humans, it suggests that microtubule inhibitors such as paclitaxel may be able to reduce scarring, fibrosis and promote nerve regeneration at the site of traumatic nerve injury.

This research is well worth reading about, and may lead to the development of new products or treatments for spinal cord injury.

, , , , , , , , , , , , , , , , , , ,

error: Content is protected !!